MedPath

Role of BharamgyÄ?di leha and (Ayurveda Medicine) HaridrÄ?di dhÅ«ma in the form of leha and Varti in the Management of Tamaka Å vÄ?sa.

Phase 2
Conditions
Health Condition 1: J459- Other and unspecified asthma
Registration Number
CTRI/2022/07/044103
Lead Sponsor
ational Institute Of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patient having classical signs and symptoms of Tamaka Å?vÄ?sa (Bronchial Asthma).

2. Patient ready to give written informed consent.

3. Age group between 18-70 years of either sex.

Exclusion Criteria

1. Age below 18 and above 70 years.

2. Patient having history of severe COPD, Emphysema, Tuberculosis, other complicated respiratory disease having any organic lesion such as tumor or any anatomical defect in airway.

3. Uncontrolled Diabetes mellitus with serious complications.

4. Uncontrolled Hypertension.

5. Pregnant women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in the Spirometry measures for Lung functions.Timepoint: at the time of screening and after completion of trial
Secondary Outcome Measures
NameTimeMethod
1. Å?vÄ?sa ká¹?cchatÄ? (Dyspnoea) <br/ ><br>2. PÄ«nasa (Nasal discharge) <br/ ><br>3. KÄ?sa (Cough) <br/ ><br>4. Kapha NiṣṭhÄ«vana(Expectoration) <br/ ><br>5. Ghurghurakama Å?abda (Wheezing) <br/ ><br>6. UraÅ?Å«la(Chest pain)Timepoint: at the time of screening and after completion of trial
© Copyright 2025. All Rights Reserved by MedPath